Drug delivery is one of the most significant application areas for biodegradable polymers. Poly Lactic Co Glycolic Acid can be formulated into microspheres and nanoparticles capable of encapsulating therapeutic compounds and releasing them over controlled periods.

The poly lactic co glycolic acid market is benefiting from increasing demand for advanced drug delivery systems. MRFR projects the overall market to increase from USD 2.025 billion in 2025 to USD 7.647 billion by 2035, representing a CAGR of 14.21%.

PLGA is particularly useful because its degradation characteristics can be adjusted through polymer composition, molecular weight, particle size, and formulation design.

Microspheres can provide sustained release of therapeutic agents, reducing the frequency of administration for certain treatments. This characteristic has made PLGA relevant to pharmaceutical formulation research.

Nanoparticles provide another important opportunity. Their small size can support specialized drug delivery strategies, including targeted delivery and improved bioavailability.

The growing prevalence of chronic diseases is increasing interest in therapies that can improve treatment effectiveness and patient convenience.

PLGA can also be used to protect sensitive pharmaceutical compounds from degradation before they reach their intended site of action.

Pharmaceutical companies and biotechnology organizations are investing in research focused on personalized medicine and targeted therapies. These developments can create additional applications for PLGA-based delivery systems.

Regulatory and manufacturing considerations remain important because pharmaceutical-grade polymers must meet stringent quality requirements.

North America has a strong position because of its pharmaceutical research infrastructure and advanced healthcare system. Europe also has significant activity in biomedical materials, while Asia-Pacific is experiencing rapid expansion in pharmaceutical manufacturing and biotechnology.

As drug delivery technologies become more sophisticated, PLGA is expected to remain an important biodegradable polymer for controlled-release formulations and emerging therapeutic applications.